Contactless magneto-permeabilization for intracellular plasmid DNA delivery in vivo

被引:38
作者
Kardos, Thomas J. [1 ]
Rabussay, Dietmar P. [1 ]
机构
[1] MagneGene Inc, Laguna Hills, CA USA
关键词
contactless; magnetic; induction; electroporation; magnetoporation; electropermeabilization; magnetopermeabilization; DNA delivery; ELECTROPORATION; EXPRESSION; THERAPY; SYSTEM; DRUG;
D O I
10.4161/hv.21576
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Electroporation, an attractive process for delivering DNA and other molecules into target cells in vivo and in vitro is limited by the necessity of electrodes that need to be in contact with the subject or object to be electroporated. We have used magnetic fields, which do not require material contact with the subject, to temporarily permeabilize cells in guinea pig skin in vivo to enhance uptake and expression of GFP plasmid DNA. The results show for the first time that magnetic fields can trigger a process likely similar to electroporation. In designing the magnetic pulses, our most important criterion was a high rate of change of the magnetic field, based on the principle described by Michael Faraday which is expressed by the formula: E = -dB/dt, (E, electric field, B, magnetic field, t, time). Magnetic fields were generated by a flat electromagnet in a hand-held applicator positioned above the target tissue. The magnetic pulses had a peak magnetic flux density of 4 tesla; 50 pulses were applied in 5 sec. Biphasic magnetic pulses were twice as effective as monophasic pulses and about equally effective as traditional electroporation pulses. Advantages of magnetopermeabilization over electoporation include: No contact between applicator and subject ("contact-less"); no need for invasive, disposable, sterile electrodes ("needle-less"); no pain from needles and reduced overall pain; no known side effects; easier and faster to administer than electroporation; less expensive due to absence of disposables; and, importantly, greater tissue penetration of the magnetic field allowing treatment of anatomical areas inaccessible by electroporation.
引用
收藏
页码:1707 / 1713
页数:7
相关论文
共 23 条
[1]   Nucleic Acids Electrotransfer In Vivo: Mechanisms and Practical Aspects [J].
Andre, Franck M. ;
Mir, Lluis M. .
CURRENT GENE THERAPY, 2010, 10 (04) :267-280
[2]   Needle-free topical electroporation improves gene expression from plasmids administered in porcine skin [J].
Babiuk, S ;
Baca-Estrada, ME ;
Foldvari, M ;
Baizer, L ;
Stout, R ;
Storms, M ;
Rabussay, D ;
Widera, G ;
Babiuk, L .
MOLECULAR THERAPY, 2003, 8 (06) :992-998
[3]  
Breton M, 2011, BIOELECTROM IN PRESS
[4]   Piezoelectric permeabilization of mammalian dermal tissue for in vivo DNA delivery leads to enhanced protein expression and increased immunogenicity [J].
Broderick, Kate E. ;
Kardos, Thomas ;
McCoy, Jay R. ;
Fons, Michael P. ;
Kemmerrer, Stephen ;
Sardesai, Niranjan Y. .
HUMAN VACCINES, 2011, 7 :22-28
[5]   Enhancement of antigen specific humoral immune responses after delivery of a DNA plasmid based vaccine through a contact-independent helium plasma [J].
Connolly, Richard J. ;
Rey, Jose I. ;
Lambert, Vance M. ;
Wegerif, Garrett ;
Jaroszeski, Mark J. ;
Ugen, Kenneth E. .
VACCINE, 2011, 29 (39) :6781-6784
[6]   Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor [J].
Daud, Adil I. ;
Mirza, Noweeda ;
Lenox, Brianna ;
Andrews, Stephanie ;
Urbas, Patricia ;
Gao, Gui X. ;
Lee, Ji-Hyun ;
Sondak, Vernon K. ;
Riker, Adam I. ;
DeConti, Ronald C. ;
Gabrilovich, Dmitry .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (19) :3235-3241
[7]  
Gehl Julie, 2008, V423, P351, DOI 10.1007/978-1-59745-194-9_27
[8]   Electro-gene transfer to skin using a noninvasive multielectrode array [J].
Guo, Siqi ;
Donate, Amy ;
Basu, Gaurav ;
Lundberg, Cathryn ;
Heller, Loree ;
Heller, Richard .
JOURNAL OF CONTROLLED RELEASE, 2011, 151 (03) :256-262
[9]  
Hofmann GA, 2000, US patent, Patent No. [6132419, 6,132,419]
[10]   Update on non-viral delivery methods for cancer therapy: possibilities of a drug delivery system with anticancer activities beyond delivery as a new therapeutic tool [J].
Kaneda, Yasufumi .
EXPERT OPINION ON DRUG DELIVERY, 2010, 7 (09) :1079-1093